Adult-Onset Still's Disease: Molecular Pathophysiology and Therapeutic Advances.

Key Findings

• ●NLRP3 inflammasome dysregulation central to pathogenesis
• ●NETs activate NLRP3 and inflammatory macrophages creating self-amplifying loop
• ●Comprehensive review of emerging therapies including JAK inhibitors

Referenced in (1 disease)

1. passsource metadataJun 1, 2026, 04:40 PMby pubmed-api

   Identifier corrected: prior entry (pmid-36430339) had a wrong PMID/DOI pointing to an unrelated paper; re-resolved by title to this record via PubMed/Crossref.

   tools: pubmed.esummary, crossref.works